Company Overview and News

 
Prospective Resource Increased 240% to 3.3 TCF

2018-04-04 globenewswire
ASX disclosure note - 5.28.2 - The estimated quantities of petroleum that may potentially be recovered by the application of a future development project(s) relate to undiscovered accumulations. These estimates have both an associated risk of discovery and a risk of development. Further exploration appraisal and evaluation is required to determine the existence of a significant quantity of potentially moveable hydrocarbons.
Upvote Downvote

 
Strata-X Triples Botswana Land Position

2018-03-20 globenewswire
ASX disclosure note - 5.28.2 - The estimated quantities of petroleum that may potentially be recovered by the application of a future development project(s) relate to undiscovered accumulations. These estimates have both an associated risk of discovery and a risk of development. Further exploration appraisal and evaluation is required to determine the existence of a significant quantity of potentially moveable hydrocarbons.
Upvote Downvote

1
Strata-X Energy gains full control of African coal seam gas project

2018-01-03 proactiveinvestors.com.au
Strata-X Energy Ltd (ASX:SXA) has gained full control of the Serowe Coal Seam Gas Project in Botswana.
Upvote Downvote

 
BRIEF-Strata-X Energy Says Pre-Empted Third Party Offer To Buy Out Magnum Power And Gas's 25 Pct Interest In Serowe CSG Project

2018-01-02 reuters
* STRATA-X ENERGY - CO HAS PRE-EMPTED A THIRD PARTY OFFER TO BUY OUT MAGNUM POWER AND GAS‘S 25% INTEREST IN SEROWE COAL SEAM GAS PROJECT Source text for Eikon: Further company coverage:
Upvote Downvote

 
Strata-X Disposes of Non-Core Wyoming Asset

2017-05-03 marketwired
DENVER, CO and BRISBANE, AUSTRALIA and VANCOUVER, BC--(Marketwired - May 02, 2017) - The directors and management of Strata-X Energy Ltd. ("Strata-X" or the "Company") (TSX VENTURE: SXE) (ASX: SXA) announce that the Company is disposing of a historical working interest in an oil and gas lease ("Lease") located in Campbell County, Wyoming, USA. The Company has determined that the Lease is a non-core asset and plans to use available capital on advancing its core assets such as the Serowe CSG Project in the Republic of Botswana and the evaluation of new ventures.
Upvote Downvote

 
Significant Progress Achieved at Serowe Project

2017-04-12 marketwired
The directors and management of Strata-X Energy Ltd. ("Strata-X" or the "Company") (TSX VENTURE: SXE) (ASX: SXA) are pleased to provide an update on the Serowe Coal Seam Gas Project in Botswana. As announced previously, the Company has farmed into approximately 273,000 acres in the Kalahari Basin CSG Fairway and has the opportunity to achieve a 75% working interest in the project, which has an estimated 1.
Upvote Downvote

 
Strata-X Prepares for 2017 Serowe Programme

2017-03-01 marketwired
The directors and management of Strata-X Energy Ltd. ("Strata-X" or the "Company") (TSX VENTURE: SXE) (ASX: SXA) are pleased to announce that it is advancing its Serowe CSG Project ("Project"), located in the Republic of Botswana, through the establishment of in-country operating subsidiary, Rhino CBM (Pty), Ltd ("Rhino"). With the establishment of Rhino, the Company has initiated the process of transferring into the entity the 273,000 gross acres of prospecting licenses that target the rich coal seam gas resource.
Upvote Downvote

 
Interim Results

2016-12-22 londonstockexchange
Empyrean, the oil and gas company, is pleased to provide its Interim Report for the six months ended 30 September 2016.
Upvote Downvote

 
[Press] Range Resources: Trinidad drilling programme update

2016-12-05 oilvoice
Range is pleased to announce that the QUN 160 development well in Trinidad that spudded on 9 November 2016 was successfully drilled to a total depth of 2,140 feet on 22 November 2016. The well was originally planned to be drilled to 2,600 feet, however it was decided not to drill below 2,140 feet as the main target (Upper Cruse formation) had been encountered at this depth and drilling of the additional footage would have contributed to an increase in drilling cost with little to no benefit.
Upvote Downvote

 
[Press] Genel Energy: Receipt of payment for KRI oil exports from Tawke field

2016-12-05 oilvoice
Genel Energy plc notes the announcement from DNO ASA, as operator of the Tawke field, that the Tawke field partners have received a payment of $36.20 million from the KurdistanRegional Government for oil sales during September 2016. The payment reflects full settlement of the invoiced amount for September 2016 oil sales, and includes $30.36 million towards the monthly entitlement and $5.84 million towards recovery of historical receivables.
Upvote Downvote

 
[Press] Aminex provides operational update for Ruvuma PSA and Kiliwani North Development Licence

2016-12-05 oilvoice
Aminex today provides an operational update for the Ruvuma PSA and the Kiliwani North Development Licence. The Company confirms that an independent inspection of the Caroil 2 drilling rig has now been completed and the Ntorya-2 appraisal well is now expected to be spudded mid-December.  The Company has a 75% operated interest in the well and initial results are expected early next year.  The well location is a 1,500-metre step-out from the Company's Ntorya-1 discovery which flow-tested gas at 20 mmcf/d, with 139 barrels of associated condensate, from a 3.
Upvote Downvote

 
[Press] Volga Gas: Production Report for November 2016

2016-12-05 oilvoice
Volga Gas plc, the oil and gas exploration and production group operating in the Volga Region of Russia, is pleased to its average production volumes for November 2016 and for the year to date. During November 2016, gas processing capacity was temporarily reduced while undertaking the testing of new chemicals for gas sweetening, as well as planned maintenance downtime of the plant for one week.  Consequently, average Group production for November 2016 was 5,454 barrels of oil equivalent per day (27% lower than October 2016).
Upvote Downvote

 
[Press] BHI Rig Count: U.S. +4 to 597, Canada +26 to 200

2016-12-05 oilvoice
BHI Rig Count: U.S. +4 to 597 rigs U.S. Rig Count is up 4 rigs from last week to 597, with oil rigs up 3 to 477, gas rigs up 1 to 119, and miscellaneous rigs unchanged at 1. U.S. Rig Count is down 140 rigs from last year's count of 737, with oil rigs down 68, gas rigs down 73, and miscellaneous rigs up 1. The U.S. Offshore Rig Count is down 1 from last week to 22 and down 3 rigs year over year. BHI Rig Count: Canada +26 to 200 rigs Canadian Rig Count is up 26 rigs from last week to 200, with oil rigs up 6 to 100, gas rigs up 20 to 98, and miscellaneous rigs unchanged at 2.
Upvote Downvote

 
[Press] UK Oil & Gas Investments PLC: PEDL234 Licence, Drilling Plans & Oil in Place Update, Central Weald Basin, UK

2016-12-05 oilvoice
Strata-x Energy: Long Form Farm-in Agreement Signed and First Tranche of Capital Raising Completed for Serowe CSG Project
Upvote Downvote

 
[Opinion] Oil price, Range Resources, Aminex/Solo, And finally...

2016-12-05 oilvoice
Oil price Whilst many commentators remain unconvinced, the oil price is tracking upwards and for the moment giving the deal the benefit of the doubt. A decent spin from the 1oth December non-Opec meeting should cement, at least for the time being the situation. Range Resources Range has announced that the QUN 160 development well encountered the Upper Cruse Formation at a shallower depth than expected (2140′) which is good.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...